Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Care Access Research
Biotech
Pfizer cuts enrollment for Lyme disease trial after CRO debacle
Pfizer now expects to enroll "much less" than 18,000 people in a phase 3 Lyme disease trial, months after thousands of enrolled patients were removed.
Max Bayer
Aug 22, 2023 1:00pm
Care Access buys Brazilian research firm in regional expansion
Jul 7, 2022 9:19am
Eli Lilly taps Reify's Care Access to diversify oncology trials
Sep 28, 2021 3:00pm
Care Access Research teams up with AstraZeneca for COVID-19 work
Jan 27, 2021 8:05am
Care Access Research launches COVID-19 alliance
Apr 14, 2020 11:00am
